444 related articles for article (PubMed ID: 15277922)
1. Molecular mechanisms of the inhibitory effects of bupivacaine, levobupivacaine, and ropivacaine on sarcolemmal adenosine triphosphate-sensitive potassium channels in the cardiovascular system.
Kawano T; Oshita S; Takahashi A; Tsutsumi Y; Tomiyama Y; Kitahata H; Kuroda Y; Nakaya Y
Anesthesiology; 2004 Aug; 101(2):390-8. PubMed ID: 15277922
[TBL] [Abstract][Full Text] [Related]
2. Molecular mechanisms underlying ketamine-mediated inhibition of sarcolemmal adenosine triphosphate-sensitive potassium channels.
Kawano T; Oshita S; Takahashi A; Tsutsumi Y; Tanaka K; Tomiyama Y; Kitahata H; Nakaya Y
Anesthesiology; 2005 Jan; 102(1):93-101. PubMed ID: 15618792
[TBL] [Abstract][Full Text] [Related]
3. Molecular mechanisms of the inhibitory effects of propofol and thiamylal on sarcolemmal adenosine triphosphate-sensitive potassium channels.
Kawano T; Oshita S; Takahashi A; Tsutsumi Y; Tomiyama Y; Kitahata H; Kuroda Y; Nakaya Y
Anesthesiology; 2004 Feb; 100(2):338-46. PubMed ID: 14739809
[TBL] [Abstract][Full Text] [Related]
4. Stoichiometry of sulfonylurea-induced ATP-sensitive potassium channel closure.
Dörschner H; Brekardin E; Uhde I; Schwanstecher C; Schwanstecher M
Mol Pharmacol; 1999 Jun; 55(6):1060-6. PubMed ID: 10347249
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of etomidate and midazolam on vascular adenosine triphosphate-sensitive potassium channels: isometric tension and patch clamp studies.
Nakamura A; Kawahito S; Kawano T; Nazari H; Takahashi A; Kitahata H; Nakaya Y; Oshita S
Anesthesiology; 2007 Mar; 106(3):515-22. PubMed ID: 17325510
[TBL] [Abstract][Full Text] [Related]
6. Different molecular sites of action for the KATP channel inhibitors, PNU-99963 and PNU-37883A.
Cui Y; Tinker A; Clapp LH
Br J Pharmacol; 2003 May; 139(1):122-8. PubMed ID: 12746230
[TBL] [Abstract][Full Text] [Related]
7. The inhibitory effects of bupivacaine, levobupivacaine, and ropivacaine on K2P (two-pore domain potassium) channel TREK-1.
Shin HW; Soh JS; Kim HZ; Hong J; Woo DH; Heo JY; Hwang EM; Park JY; Lee CJ
J Anesth; 2014 Feb; 28(1):81-6. PubMed ID: 23797625
[TBL] [Abstract][Full Text] [Related]
8. Proximal C-terminal domain of sulphonylurea receptor 2A interacts with pore-forming Kir6 subunits in KATP channels.
Rainbow RD; James M; Hudman D; Al Johi M; Singh H; Watson PJ; Ashmole I; Davies NW; Lodwick D; Norman RI
Biochem J; 2004 Apr; 379(Pt 1):173-81. PubMed ID: 14672537
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of cardiac sarcolemmal adenosine triphosphate-sensitive potassium channel activation by isoflurane in a heterologous expression system.
Bienengraeber M; Warltier DC; Bosnjak ZJ; Stadnicka A
Anesthesiology; 2006 Sep; 105(3):534-40. PubMed ID: 16931986
[TBL] [Abstract][Full Text] [Related]
10. Interaction of a novel dihydropyridine K+ channel opener, A-312110, with recombinant sulphonylurea receptors and KATP channels: comparison with the cyanoguanidine P1075.
Felsch H; Lange U; Hambrock A; Löffler-Walz C; Russ U; Carroll WA; Gopalakrishnan M; Quast U
Br J Pharmacol; 2004 Apr; 141(7):1098-105. PubMed ID: 15023854
[TBL] [Abstract][Full Text] [Related]
11. The Kir6.2-F333I mutation differentially modulates KATP channels composed of SUR1 or SUR2 subunits.
Tammaro P; Ashcroft F
J Physiol; 2007 Jun; 581(Pt 3):1259-69. PubMed ID: 17395632
[TBL] [Abstract][Full Text] [Related]
12. Effects of intracellular MgADP and acidification on the inhibition of cardiac sarcolemmal ATP-sensitive potassium channels by propofol.
Yamada H; Kawano T; Tanaka K; Yasui S; Mawatari K; Takahashi A; Nakaya Y; Oshita S
J Anesth; 2007; 21(4):472-9. PubMed ID: 18008114
[TBL] [Abstract][Full Text] [Related]
13. Involvement of the n-terminus of Kir6.2 in coupling to the sulphonylurea receptor.
Reimann F; Tucker SJ; Proks P; Ashcroft FM
J Physiol; 1999 Jul; 518 ( Pt 2)(Pt 2):325-36. PubMed ID: 10381582
[TBL] [Abstract][Full Text] [Related]
14. A key role for the subunit SUR2B in the preferential activation of vascular KATP channels by isoflurane.
Fujita H; Ogura T; Tamagawa M; Uemura H; Sato T; Ishida A; Imamaki M; Kimura F; Miyazaki M; Nakaya H
Br J Pharmacol; 2006 Nov; 149(5):573-80. PubMed ID: 17001304
[TBL] [Abstract][Full Text] [Related]
15. C-terminal tails of sulfonylurea receptors control ADP-induced activation and diazoxide modulation of ATP-sensitive K(+) channels.
Matsuoka T; Matsushita K; Katayama Y; Fujita A; Inageda K; Tanemoto M; Inanobe A; Yamashita S; Matsuzawa Y; Kurachi Y
Circ Res; 2000 Nov; 87(10):873-80. PubMed ID: 11073882
[TBL] [Abstract][Full Text] [Related]
16. Effect of repaglinide on cloned beta cell, cardiac and smooth muscle types of ATP-sensitive potassium channels.
Dabrowski M; Wahl P; Holmes WE; Ashcroft FM
Diabetologia; 2001 Jun; 44(6):747-56. PubMed ID: 11440368
[TBL] [Abstract][Full Text] [Related]
17. Nateglinide, a D-phenylalanine derivative lacking either a sulfonylurea or benzamido moiety, specifically inhibits pancreatic beta-cell-type K(ATP) channels.
Chachin M; Yamada M; Fujita A; Matsuoka T; Matsushita K; Kurachi Y
J Pharmacol Exp Ther; 2003 Mar; 304(3):1025-32. PubMed ID: 12604678
[TBL] [Abstract][Full Text] [Related]
18. Remodelling of the SUR-Kir6.2 interface of the KATP channel upon ATP binding revealed by the conformational blocker rhodamine 123.
Hosy E; Dérand R; Revilloud J; Vivaudou M
J Physiol; 2007 Jul; 582(Pt 1):27-39. PubMed ID: 17510180
[TBL] [Abstract][Full Text] [Related]
19. Potassium channel openers require ATP to bind to and act through sulfonylurea receptors.
Schwanstecher M; Sieverding C; Dörschner H; Gross I; Aguilar-Bryan L; Schwanstecher C; Bryan J
EMBO J; 1998 Oct; 17(19):5529-35. PubMed ID: 9755153
[TBL] [Abstract][Full Text] [Related]
20. Sulfonylurea receptors type 1 and 2A randomly assemble to form heteromeric KATP channels of mixed subunit composition.
Chan KW; Wheeler A; Csanády L
J Gen Physiol; 2008 Jan; 131(1):43-58. PubMed ID: 18079561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
